200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 141801-26-5

141801-26-5

141801-26-5 | L-Phenylalaninamide, L-tyrosyl-L-prolyl-L-phenylalanyl-

CAS No: 141801-26-5 Catalog No: AG001H7A MDL No:

Product Description

Catalog Number:
AG001H7A
Chemical Name:
L-Phenylalaninamide, L-tyrosyl-L-prolyl-L-phenylalanyl-
CAS Number:
141801-26-5
Molecular Formula:
C32H37N5O5
Molecular Weight:
571.6667
IUPAC Name:
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
InChI:
InChI=1S/C32H37N5O5/c33-25(18-23-13-15-24(38)16-14-23)32(42)37-17-7-12-28(37)31(41)36-27(20-22-10-5-2-6-11-22)30(40)35-26(29(34)39)19-21-8-3-1-4-9-21/h1-6,8-11,13-16,25-28,38H,7,12,17-20,33H2,(H2,34,39)(H,35,40)(H,36,41)/t25-,26-,27-,28-/m0/s1
InChI Key:
XIJHWXXXIMEHKW-LJWNLINESA-N
SMILES:
Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)Cc1ccccc1)N
UNII:
3PH5M0466G

Properties

Complexity:
911  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
4  
Defined Bond Stereocenter Count:
0
Exact Mass:
571.279g/mol
Formal Charge:
0
Heavy Atom Count:
42  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
5  
Isotope Atom Count:
0
Molecular Weight:
571.678g/mol
Monoisotopic Mass:
571.279g/mol
Rotatable Bond Count:
12  
Topological Polar Surface Area:
168A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  

Literature

Title Journal
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2. Journal of medicinal chemistry 20160922
Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic. Biopolymers 20160501
Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission. Peptides 20140101
Highly efficient synthesis of endomorphin-2 under thermodynamic control catalyzed by organic solvent stable proteases with in situ product removal. Bioresource technology 20130201
The effect of Pro(2) modifications on the structural and pharmacological properties of endomorphin-2. Journal of medicinal chemistry 20121011
cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2. Journal of medicinal chemistry 20121011
Characterization of antinociceptive potency of endomorphin-2 derivatives with unnatural amino acids in rats. Acta physiologica Hungarica 20120901
Endomorphin-2: a biased agonist at the μ-opioid receptor. Molecular pharmacology 20120801
Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs. Medicinal research reviews 20120501
The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues. Journal of medicinal chemistry 20120412
Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic. The Journal of pharmacology and experimental therapeutics 20120101
Endogenous endomorphin-2 contributes to spinal ĸ-opioid antinociception. Pharmacology 20120101
Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs. Bioorganic & medicinal chemistry 20111201
Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue. ACS chemical biology 20111118
Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70. The Journal of neuroscience : the official journal of the Society for Neuroscience 20111109
Origins of endomorphin-2 immunopositive fibers and terminals in the rat medullary dorsal horn. Brain research 20110902
Pharmacology of a new tritiated endomorphin-2 analog containing the proline mimetic cis-2-aminocyclohexanecarboxylic acid. Peptides 20110401
Antinociception by endogenous ligands at peripheral level. Ideggyogyaszati szemle 20110330
Design, synthesis, pharmacological evaluation, and structure-activity study of novel endomorphin analogues with multiple structural modifications. Journal of medicinal chemistry 20110310
The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord. European journal of pharmacology 20110110
Effects of endomorphins on human umbilical vein endothelial cells under high glucose. Peptides 20110101
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2. European journal of medicinal chemistry 20101001
Origins of endomorphin-2 immunopositive fibers and terminals in the spinal dorsal horn of the rat. Neuroscience 20100811
Recent advances in endomorphin engineering. ChemMedChem 20100802
A protective effect of endomorphins on the oxidative injury of islet. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20100801
micro-Opioid receptor stimulation in the medial subnucleus of the tractus solitarius inhibits gastric tone and motility by reducing local GABA activity. American journal of physiology. Gastrointestinal and liver physiology 20100801
The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro. Chemical biology & drug design 20100701
Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues. Journal of medicinal chemistry 20100610
Discovery of dipeptides with high affinity to the specific binding site for substance P1-7. Journal of medicinal chemistry 20100325
Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2. Basic & clinical pharmacology & toxicology 20100201
Neurochemical phenotypes of endomorphin-2-containing neurons in vagal nodose neurons of the adult rat. Neurochemistry international 20091201
Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20091201
The effect of opioids and their antagonists on the nocifensive response of Caenorhabditis elegans to noxious thermal stimuli. Invertebrate neuroscience : IN 20091201
Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance. The Journal of pharmacology and experimental therapeutics 20091101
Intrathecally injected Ile-Pro-Ile, an inhibitor of membrane ectoenzyme dipeptidyl peptidase IV, is antihyperalgesic in rats by switching the enzyme from hydrolase to synthase functional mode to generate endomorphin 2. European journal of pharmacology 20091012
Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4,5 dorsal root ganglia by DPP-IV. Regulatory peptides 20091009
In vitro and in vivo characterization of opioid activities of C-terminal esterified endomorphin-2 analogs. Peptides 20090901
Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue. Bioorganic & medicinal chemistry letters 20090801
Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. Bioorganic & medicinal chemistry 20090601
The effects of endomorphins on striatal [3H]GABA release induced by electrical stimulation: an in vitro superfusion study in rats. Neurochemical research 20090501
Effects of transgene-mediated endomorphin-2 in inflammatory pain. European journal of pain (London, England) 20090401
Endomorphin 1- and endomorphin 2-containing neurons in nucleus tractus solitarii send axons to the parabrachial nuclei in the rat. Anatomical record (Hoboken, N.J. : 2007) 20090401
Practical aspects of in vivo detection of neuropeptides by microdialysis coupled off-line to capillary LC with multistage MS. Analytical chemistry 20090315
Cloning of opioid receptors in common carp (Cyprinus carpio L.) and their involvement in regulation of stress and immune response. Brain, behavior, and immunity 20090201
The novel micro-opioid receptor antagonist, [N-allyl-Dmt(1)]endomorphin-2, attenuates the enhancement of GABAergic neurotransmission by ethanol. Alcohol and alcoholism (Oxford, Oxfordshire) 20090101
[Endomorphins--endogenous ligands of the mu-opioid receptor]. Postepy biochemii 20090101
Functional coupling of mu-receptor-Galphai-tethered proteins in AtT20 cells. Neuroreport 20081203
Enzymatic degradation of endomorphins. Peptides 20081101
Structure-activity relationships of modified C-terminal endomorphin-2 analogues by molecular dynamics simulations. Journal of molecular graphics & modelling 20081101
Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain. Peptides 20081001
Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2. Peptides 20080901
Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2. Chemical biology & drug design 20080701
Detection of a novel immunoreactive endomorphin 2-like peptide in rat brain extracts. Regulatory peptides 20080605
The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Anesthesia and analgesia 20080601
Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line. Biochemistry and cell biology = Biochimie et biologie cellulaire 20080601
[Analysis of central mechanisms involved in gastric mucosal integrity]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20080601
Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors. Neuropharmacology 20080501
Endomorphins and morphine limit anoxia-reoxygenation-induced brain mitochondrial dysfunction in the mouse. Life sciences 20080326
Role of GABA B receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. European journal of pharmacology 20080310
Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure. Bioorganic & medicinal chemistry letters 20080215
Role of GABAA receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. European journal of pharmacology 20080202
Interactions of galanin with endomorphin-2, vasopressin and oxytocin in nociceptive modulation of the trigemino-hypoglossal reflex in rats. Physiological research 20080101
Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins. Life sciences 20071201
From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides. Peptides 20071201
A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic. Bioorganic & medicinal chemistry 20071115
[N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties. The Journal of pharmacology and experimental therapeutics 20071001
Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition. Neuropharmacology 20071001
Inhibition of opioid release in the rat spinal cord by serotonin 5-HT(1A) receptors. Brain research 20070716
Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide, gamma-aminobutyric acid, and the mu opioid receptor. The Journal of comparative neurology 20070710
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands. Journal of medicinal chemistry 20070614
Endomorphin-2-immunoreactive fibers selectively appose serotonergic neuronal somata in the rostral ventral medial medulla. The Journal of comparative neurology 20070610
A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors. European journal of pharmacology 20070601
Differential receptor binding characteristics of consecutive phenylalanines in micro-opioid specific peptide ligand endomorphin-2. Bioorganic & medicinal chemistry 20070601
Conformational analysis of endomorphin-2 analogs with phenylalanine mimics by NMR and molecular modeling. Bioorganic & medicinal chemistry 20070515
Sex-/ovarian steroid-dependent release of endomorphin 2 from spinal cord. The Journal of pharmacology and experimental therapeutics 20070501
Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070401
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorganic & medicinal chemistry letters 20070401
Structure-activity study on the spatial arrangement of the third aromatic ring of endomorphins 1 and 2 using an atypical constrained C terminus. ChemMedChem 20070301
Synthesis and analgesic activities of endomorphin-2 and its analogues. Chemistry & biodiversity 20070301
Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2). Journal of medicinal chemistry 20070208
Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists. Bioorganic & medicinal chemistry 20070201
Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat. European journal of pharmacology 20070112
The effects of endomorphins and diprotin A on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study in rats. Neurochemistry international 20061201
Synthesis, radiolabeling and receptor binding of [3H][(1S,2R)ACPC2]endomorphin-2. Peptides 20061201
Abnormal modulation of cholinergic neurotransmission by endomorphin 1 and endomorphin 2 in isolated bronchus of type 1 diabetic rats. Peptides 20061101
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. Journal of medicinal chemistry 20060907
Opioid receptor binding and antinociceptive activity of the analogues of endomorphin-2 and morphiceptin with phenylalanine mimics in the position 3 or 4. Bioorganic & medicinal chemistry letters 20060715
Endomorphin1 and endomorphin2, endogenous potent inhibitors of electrical field stimulation (EFS)-induced cholinergic contractions of rat isolated bronchus. Peptides 20060701
Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception. European journal of pharmacology 20060701
New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands. Journal of medicinal chemistry 20060629
[(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs. Biochemical and biophysical research communications 20060623
6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. Journal of medicinal chemistry 20060615
Partial and full agonism in endomorphin derivatives: comparison by null and operational model. Peptides 20060601
Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay. The Journal of pharmacology and experimental therapeutics 20060601
Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060601
Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. The Journal of neuroscience : the official journal of the Society for Neuroscience 20060419
Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2. The Journal of pharmacology and experimental therapeutics 20060401
Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins. Regulatory peptides 20060315
Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation. The FEBS journal 20060301
Endomorphin-2 in the medial NTS attenuates the responses to baroreflex activation. Brain research 20060216
Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060201
CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity. Behavioural brain research 20060130
A new electrochemical HPLC method for analysis of enkephalins and endomorphins. Journal of neuroscience methods 20060115
Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids. Peptides 20060101
C-terminal amide to alcohol conversion changes the cardiovascular effects of endomorphins in anesthetized rats. Peptides 20060101
The reciprocal connections of endomorphin 1- and endomorphin 2-containing neurons between the hypothalamus and nucleus tractus solitarii in the rat. Neuroscience 20060101
Inhibition by endomorphin-1 and endomorphin-2 of excitatory transmission in adult rat substantia gelatinosa neurons. Neuroscience 20060101
Endomorphins restored the endothelium-dependent relaxation of the rabbit aorta rings exposed to high D-glucose condition via NO-cGMP pathway. Protein and peptide letters 20060101
Endomorphin-1 is more potent than endomorphin-2 in inhibition of synaptic transmission in substantia gelatinosa of adult rat spinal cord. The International journal of neuroscience 20051101
Vasorelaxant responses to endomorphin1[psi] and endomorphin2[psi], analogues of endomorphins, in rat aorta rings. Die Pharmazie 20051101
Reduced suppression of CO2-induced ventilatory stimulation by endomorphins relative to morphine. Brain research 20051019
Structural function of C-terminal amidation of endomorphin. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid, studied by 1H-NMR spectroscopy, molecular calculation, and X-ray crystallography. The FEBS journal 20051001
Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity. The journal of peptide research : official journal of the American Peptide Society 20050901
Reduced kappa-opioid activity in a rat model of cholestasis. European journal of pharmacology 20050822
Attenuation of aortic baroreflex responses by microinjections of endomorphin-2 into the rostral ventrolateral medullary pressor area of the rat. American journal of physiology. Regulatory, integrative and comparative physiology 20050701
Aromatic-aromatic and proline-aromatic interactions in endomorphin-1 and endomorphin-2. European journal of medicinal chemistry 20050701
6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid mimics active conformation of tyrosine in opioid peptides. Bioorganic & medicinal chemistry letters 20050516
[TIC4]endomorphins, analogues of endomorphins, have significantly enhanced vasorelaxant effects in rat aorta rings. Protein and peptide letters 20050501
Cardiovascular effects of endomorphins in alloxan-induced diabetic rats. Peptides 20050401
Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2. Bioorganic & medicinal chemistry letters 20050401
Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat. The Journal of pharmacology and experimental therapeutics 20050301
Substance P and opioid peptidergic innervation of the anterior eye segment of the rat: an immunohistochemical study. Journal of anatomy 20050301
Inhibition of trigemino-hypoglossal reflex in rats by oxytocin is mediated by mu and kappa opioid receptors. Brain research 20050221
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse. European journal of pharmacology 20050210
Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2. Journal of medicinal chemistry 20050127
Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position. Biochemical pharmacology 20050101
Effects of morphine and endomorphins on the polysynaptic reflex in the isolated rat spinal cord. Naunyn-Schmiedeberg's archives of pharmacology 20050101
Postnatal development of ectopic sensory fibers containing endomorphin-2 in the white matter of the spinal cord of a transgenic mouse expressing nerve growth factor in oligodendrocytes. Neuroscience 20050101
Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain research 20041203
Depressor and bradycardic responses to microinjections of endomorphin-2 into the NTS are mediated via ionotropic glutamate receptors. American journal of physiology. Regulatory, integrative and comparative physiology 20041001
Analgesic tolerance and cross-tolerance to i.c.v. endomorphin-1, endomorphin-2, and morphine in mice. Neuroscience letters 20040812
[Development of a new analgesic based on metabolism of endomorphin, an endogenous opioid peptide]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040801
Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse. Neuroscience letters 20040729
Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord. The Journal of pharmacology and experimental therapeutics 20040701
Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties. Journal of medicinal chemistry 20040701
Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat. The Journal of pharmacology and experimental therapeutics 20040501
Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells. Experimental brain research 20040501
Co-localization of endomorphin-2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat. The European journal of neuroscience 20040401
Supraspinal anti-allodynic and rewarding effects of endomorphins in rats. Peptides 20040401
Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord. The Journal of pharmacology and experimental therapeutics 20031201
Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene. Journal of pharmacological sciences 20031201
Endomorphins, endogenous opioid peptides, provide antioxidant defense in the brain against free radical-induced damage. Biochimica et biophysica acta 20031120
Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices. British journal of pharmacology 20031101
Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. Journal of pharmacological sciences 20031101
Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study. Biochemical pharmacology 20030815
Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells. The Journal of pharmacology and experimental therapeutics 20030801
Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord. Life sciences 20030613
Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond. Bioorganic & medicinal chemistry 20030501
The antitussive effects of endomorphin-1 and endomorphin-2 in mice. European journal of pharmacology 20030425
The effect of endomorphins on the release of 3H-norepinephrine from rat nucleus tractus solitarii slices. Regulatory peptides 20030328
Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity. Bioorganic & medicinal chemistry 20030306
Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats. Peptides 20030301
Synthesis and evaluation of potential affinity labels derived from endomorphin-2. The journal of peptide research : official journal of the American Peptide Society 20030201
Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene. Neuroscience letters 20021225
Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluoro-gold injections to the ventral tegmental area. The Journal of comparative neurology 20021216
Cross-tolerance between the different mu-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat. Neuroscience letters 20021213
Endomorphin analogues containing D-Pro2 discriminate different mu-opioid receptor mediated antinociception in mice. British journal of pharmacology 20021201
Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse. The Journal of pharmacology and experimental therapeutics 20021101
Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. Journal of pharmaceutical sciences 20021001
Endomorphins suppress nociception-induced c-Fos and Zif/268 expression in the rat spinal dorsal horn. European journal of pharmacology 20020906
Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kappaB DNA binding in THP-1 differentiated to macrophage-like cells. Scandinavian journal of immunology 20020901
In vitro quantitative study of the degradation of endomorphins. Peptides 20020901
Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants. The European journal of neuroscience 20020901
The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse. Japanese journal of pharmacology 20020701
Differential antinociceptive effects induced by intrathecally-administered endomorphin-1 and endomorphin-2 in mice. Japanese journal of pharmacology 20020701
Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2. Japanese journal of pharmacology 20020701
Differential mechanism of G-protein activation induced by endogenous mu-opioid peptides, endomorphin and beta-endorphin. Japanese journal of pharmacology 20020701
Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice. European journal of pharmacology 20020620
Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation. Annals of the New York Academy of Sciences 20020601
Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone. Peptides 20020501
Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system. Drug metabolism and disposition: the biological fate of chemicals 20020301
Responses to microinjections of endomorphin and nociceptin into the medullary cardiovascular areas. Clinical and experimental pharmacology & physiology 20020301
Involvement of mu(1)-opioid receptors and cholinergic neurotransmission in the endomorphins-induced impairment of passive avoidance learning in mice. Behavioural brain research 20020201
Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats. Hormones and behavior 20020201
Endomorphins inhibit contractile responses of rat thoracic aorta rings induced by phenylephrine and angiotensin II in vitro. Acta pharmacologica Sinica 20020101
Endomorphin-2 inhibits GABAergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus. Neuroscience 20020101
Release of [Met5]enkephalin from the spinal cord by intraventricularly administered endomorphin-2, but not endomorphin-1 in the anesthetized rat. Neuroscience letters 20011204
Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice. Neuroreport 20011204
Acute antinociceptive tolerance and asymmetric cross-tolerance between endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. The Journal of pharmacology and experimental therapeutics 20011201
Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation. Journal of medicinal chemistry 20011108
Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H NMR spectroscopy and molecular modeling calculation. The journal of peptide research : official journal of the American Peptide Society 20011101
Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment. Brain research 20010921
Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. European journal of pharmacology 20010921
Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain. Neuroscience letters 20010921
Partial agonistic action of endomorphins in the mouse spinal cord. Neuroscience letters 20010907
Endomorphins 1 and 2 modulate chemotaxis, phagocytosis and superoxide anion production by microglia. Journal of neuroimmunology 20010903
Behavioral and neuroendocrine actions of endomorphin-2. Peptides 20010901
Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. The Journal of pharmacology and experimental therapeutics 20010801
Effects of loperamide and other opioid-related substances on the transcriptional regulation of the rat pro-opiomelanocortin gene in AtT20 cells. Neuroendocrinology 20010801
Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neuroscience letters 20010727
Saturable brain-to-blood transport of endomorphins. Experimental brain research 20010701
Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice. European journal of pharmacology 20010608
Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin. The Journal of neuroscience : the official journal of the Society for Neuroscience 20010601
Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy. European journal of pharmacology 20010601
Endomorphins and activation of the hypothalamo-pituitary-adrenal axis. The Journal of endocrinology 20010401
Role of cholecystokinin in the reduction of endomorphin-2-induced antinociception in diabetic mice. European journal of pharmacology 20010323
Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects. Synapse (New York, N.Y.) 20010301
Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neuroscience 20010101
Endomorphin and mu-opioid receptors in mouse brain mediate the analgesic effect induced by 2 Hz but not 100 Hz electroacupuncture stimulation. Neuroscience letters 20001124
Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine. American journal of respiratory and critical care medicine 20000901
G protein activation by endomorphins in the mouse periaqueductal gray matter. Journal of biomedical science 20000101
Endomorphin-1 and endomorphin-2 activate mu-opioid receptors in myenteric neurons of the guinea-pig small intestine. Naunyn-Schmiedeberg's archives of pharmacology 19981201
Endomorphins fully activate a cloned human mu opioid receptor. FEBS letters 19981113
A potent and selective endogenous agonist for the mu-opiate receptor. Nature 19970403

© 2019 Angene International Limited. All rights Reserved.